Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Reply to: "Experimental aspects of copy number variant assays at CCL3L1".

He W, Kulkarni H, Castiblanco J, Shimizu C, Aluyen U, Maldonado R, Carrillo A, Griffin M, Lipsitt A, Beachy L, Shostakovich-Koretskaya L, Mangano A, Sen L, Nibbs RJ, Tiemessen CT, Bolivar H, Bamshad MJ, Clark RA, Burns JC, Dolan MJ, Ahuja SK.

Nat Med. 2009 Oct;15(10):1117-20. doi: 10.1038/nm1009-1117. No abstract available.

PMID:
19812563
2.

Experimental aspects of copy number variant assays at CCL3L1.

Field SF, Howson JM, Maier LM, Walker S, Walker NM, Smyth DJ, Armour JA, Clayton DG, Todd JA.

Nat Med. 2009 Oct;15(10):1115-7. doi: 10.1038/nm1009-1115. No abstract available.

3.

Gene copy number: learning to count past two.

Shrestha S, Tang J, Kaslow RA.

Nat Med. 2009 Oct;15(10):1127-9. doi: 10.1038/nm1009-1127. No abstract available.

PMID:
19812568
4.

CCL3L1 and HIV/AIDS susceptibility.

Bhattacharya T, Stanton J, Kim EY, Kunstman KJ, Phair JP, Jacobson LP, Wolinsky SM.

Nat Med. 2009 Oct;15(10):1112-5. doi: 10.1038/nm1009-1112. No abstract available.

PMID:
19812561
5.

CCL3L1 and HIV/AIDS susceptibility.

Urban TJ, Weintrob AC, Fellay J, Colombo S, Shianna KV, Gumbs C, Rotger M, Pelak K, Dang KK, Detels R, Martinson JJ, O'Brien SJ, Letvin NL, McMichael AJ, Haynes BF, Carrington M, Telenti A, Michael NL, Goldstein DB.

Nat Med. 2009 Oct;15(10):1110-2. doi: 10.1038/nm1009-1110. No abstract available.

6.

The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility.

Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, Catano G, Nibbs RJ, Freedman BI, Quinones MP, Bamshad MJ, Murthy KK, Rovin BH, Bradley W, Clark RA, Anderson SA, O'connell RJ, Agan BK, Ahuja SS, Bologna R, Sen L, Dolan MJ, Ahuja SK.

Science. 2005 Mar 4;307(5714):1434-40. Epub 2005 Jan 6.

7.

CCL3L1-CCR5 genotype improves the assessment of AIDS Risk in HIV-1-infected individuals.

Kulkarni H, Agan BK, Marconi VC, O'Connell RJ, Camargo JF, He W, Delmar J, Phelps KR, Crawford G, Clark RA, Dolan MJ, Ahuja SK.

PLoS One. 2008 Sep 8;3(9):e3165. doi: 10.1371/journal.pone.0003165.

8.

CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals.

Ahuja SK, Kulkarni H, Catano G, Agan BK, Camargo JF, He W, O'Connell RJ, Marconi VC, Delmar J, Eron J, Clark RA, Frost S, Martin J, Ahuja SS, Deeks SG, Little S, Richman D, Hecht FM, Dolan MJ.

Nat Med. 2008 Apr;14(4):413-20. doi: 10.1038/nm1741. Epub 2008 Mar 30.

9.

Copy number variations of CCL3L1 and long-term prognosis of HIV-1 infection in asymptomatic HIV-infected Japanese with hemophilia.

Nakajima T, Ohtani H, Naruse T, Shibata H, Mimaya JI, Terunuma H, Kimura A.

Immunogenetics. 2007 Oct;59(10):793-8. Epub 2007 Sep 14.

PMID:
17874089
10.

Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis.

McKinney C, Merriman ME, Chapman PT, Gow PJ, Harrison AA, Highton J, Jones PB, McLean L, O'Donnell JL, Pokorny V, Spellerberg M, Stamp LK, Willis J, Steer S, Merriman TR.

Ann Rheum Dis. 2008 Mar;67(3):409-13. Epub 2007 Jun 29.

PMID:
17604289
11.

Lower copy numbers of the chemokine CCL3L1 gene in patients with chronic hepatitis C.

Grünhage F, Nattermann J, Gressner OA, Wasmuth HE, Hellerbrand C, Sauerbruch T, Spengler U, Lammert F.

J Hepatol. 2010 Feb;52(2):153-9. doi: 10.1016/j.jhep.2009.11.001. Epub 2009 Nov 27.

PMID:
20044164
12.

Association of CCR5-59029 A/G and CCL3L1 copy number polymorphism with HIV type 1 transmission/progression among HIV type 1-seropositive and repeatedly sexually exposed HIV type 1-seronegative North Indians.

Rathore A, Chatterjee A, Sivarama P, Yamamoto N, Singhal PK, Dhole TN.

AIDS Res Hum Retroviruses. 2009 Nov;25(11):1149-56. doi: 10.1089/aid.2008.0019.

PMID:
19886839
13.

CCL3L1 dose and HIV-1 susceptibility.

Mackay CR.

Trends Mol Med. 2005 May;11(5):203-6. Review.

PMID:
15882607
14.

CCL3L1 copy number variation and susceptibility to HIV-1 infection: a meta-analysis.

Liu S, Yao L, Ding D, Zhu H.

PLoS One. 2010 Dec 30;5(12):e15778. doi: 10.1371/journal.pone.0015778.

15.

HIV-1/AIDS susceptibility and copy number variation in CCL3L1, a gene encoding a natural ligand for HIV-1 co-receptor CCR5.

Nakajima T, Kaur G, Mehra N, Kimura A.

Cytogenet Genome Res. 2008;123(1-4):156-60. doi: 10.1159/000184703. Epub 2009 Mar 11. Review.

PMID:
19287150
16.

Influence of variations in CCL3L1 and CCR5 on tuberculosis in a northwestern Colombian population.

Mamtani M, Mummidi S, Ramsuran V, Pham MH, Maldonado R, Begum K, Valera MS, Sanchez R, Castiblanco J, Kulkarni H, Ndung'u T, He W, Anaya JM, Ahuja SK.

J Infect Dis. 2011 Jun 1;203(11):1590-4. doi: 10.1093/infdis/jir145.

17.

HIV/AIDS. HIV: experiencing the pressures of modern life.

Nolan D, James I, Mallal S.

Science. 2005 Mar 4;307(5714):1422-4. No abstract available.

PMID:
15746416
18.

The impact of CCL3L1 copy number in an HIV-1-infected white population.

Lee EY, Yue FY, Jones RB, Lo C, Sheth P, Hyrcza MD, Kovacs C, Benko E, Kaul R, Ostrowski M.

AIDS. 2010 Jun 19;24(10):1589-91. doi: 10.1097/QAD.0b013e3283398294.

PMID:
20442635
19.

Genotype and allele frequency of a 32-base pair deletion mutation in the CCR5 gene in various ethnic groups: absence of mutation among Asians and Pacific Islanders.

Lu Y, Nerurkar VR, Dashwood WM, Woodward CL, Ablan S, Shikuma CM, Grandinetti A, Chang H, Nguyen HT, Wu Z, Yamamura Y, Boto WO, Merriwether A, Kurata T, Detels R, Yanagihara R.

Int J Infect Dis. 1999 Summer;3(4):186-91.

PMID:
10575146
20.

CCL3L1 copy number, CCR5 genotype and susceptibility to tuberculosis.

Carpenter D, Taype C, Goulding J, Levin M, Eley B, Anderson S, Shaw MA, Armour JA.

BMC Med Genet. 2014 Jan 9;15:5. doi: 10.1186/1471-2350-15-5.

Supplemental Content

Support Center